Companies

Damora Therapeutics, Inc. (DMRA) SEC filings

CIK 0001800315 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Net income (USD)-38.3 M-61.6 M-51.8 M
Diluted EPS (USD/shares)3.98-36.08-2.43

Latest filings

FiledFormDescriptionPeriod
2026-09-28442026-09-25
2026-08-13442026-08-12
2026-08-13332026-08-12
2026-08-12EFFECTEFFECT items ,,
2026-08-10S-8 POSS-8 POS
2026-08-10S-8 POSS-8 POS
2026-08-10POSASRPOSASR
2026-08-10S-8 POSS-8 POS
2026-08-10S-8 POSS-8 POS
2026-08-10S-8 POSS-8 POS
2026-08-10S-8 POSS-8 POS
2026-08-10S-8 POSS-8 POS
2026-08-10S-8 POSS-8 POS
2026-08-10POS AMPOS AM
2026-08-108-A12B/A8-A12B/A
2026-08-1010-Q10-Q2026-06-30
2026-08-06144144
2026-07-28SCHEDULE 13GSCHEDULE 13G
2026-07-208-K8-K items 1.01,3.03,5.03,7.01,9.012026-07-16
2026-07-07442026-07-03
2026-06-22144144
2026-06-178-K8-K items 5.072026-04-28
2026-05-15SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-15SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-15SCHEDULE 13GSCHEDULE 13G

Forms on file (last 1,000): 4 106, 8-K 40, 144 38, 3 29, 10-Q 18, SCHEDULE 13G 9, S-8 POS 8, S-8 8. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=DMRA (0.002 USD), /gw/filings/filings?ticker=DMRA&form=8-K, /gw/filings/facts?ticker=DMRA&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange